Reijo Juhani Salonen
Direktor/Vorstandsmitglied bei Suomen Lääketieteen Säätiö sr
Profil
Reijo Juhani Salonen is currently the Director at DelSiTech Oy, the Director at Suomen Lääketieteen Säätiö sr since 2011, and the Director at Finnish Foundation for Research on Viral Diseases since 2009.
Previously, he held positions such as Director at the European Federation of Pharmaceutical Industries & Assns from 2007 to 2012, Director-Medical Strategy & Communications at Glaxo Wellcome, Inc. from 1995 to 2001, Chief Medical Officer and SVP-Research & Development at Orion Oyj from 2006 to 2017, VP-Clinical Development & Medical Affairs at GlaxoSmithKline Oy from 2001 to 2004, VP-Neurology, Psychiatry & Ophthalmology at Pfizer Oy from 2004 to 2006, and Member-Industry Board at the European Brain Council from 2006 to 2014.
He obtained his doctorate degree from the University of Turku in 1983.
Aktive Positionen von Reijo Juhani Salonen
Unternehmen | Position | Beginn |
---|---|---|
Suomen Lääketieteen Säätiö sr | Direktor/Vorstandsmitglied | 01.01.2011 |
Finnish Foundation for Research on Viral Diseases | Direktor/Vorstandsmitglied | 01.01.2009 |
DelSiTech Oy
DelSiTech Oy Pharmaceuticals: MajorHealth Technology DelSiTech Ltd develops therapeutic delivery technology and drug formulations. Its services include small molecule drug delivery, delivery solutions for biological macromolecus, virus vector delivery, manufacturing service, and analytical service. The company was founded by Harry Jalonen in 2001, and is headquartered in Turku, Finland. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Reijo Juhani Salonen
Unternehmen | Position | Ende |
---|---|---|
ORION OYJ | Technik-/Wissenschafts-/F&E-Leiter | 21.02.2017 |
European Brain Council | Direktor/Vorstandsmitglied | 01.01.2014 |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Direktor/Vorstandsmitglied | 01.01.2012 |
Pfizer Oy | Corporate Officer/Principal | 01.01.2006 |
Glaxosmithkline Oy
Glaxosmithkline Oy Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Oy is a Finnish company that manufactures pharmaceutical products. The company is based in Espoo, Finland. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 |
Ausbildung von Reijo Juhani Salonen
University of Turku | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ORION OYJ | Health Technology |
Private Unternehmen | 8 |
---|---|
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Commercial Services |
Suomen Lääketieteen Säätiö sr | |
Finnish Foundation for Research on Viral Diseases | |
European Brain Council | |
Pfizer Oy | |
Glaxosmithkline Oy
Glaxosmithkline Oy Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Oy is a Finnish company that manufactures pharmaceutical products. The company is based in Espoo, Finland. | Health Technology |
Glaxo Wellcome, Inc. | Health Technology |
DelSiTech Oy
DelSiTech Oy Pharmaceuticals: MajorHealth Technology DelSiTech Ltd develops therapeutic delivery technology and drug formulations. Its services include small molecule drug delivery, delivery solutions for biological macromolecus, virus vector delivery, manufacturing service, and analytical service. The company was founded by Harry Jalonen in 2001, and is headquartered in Turku, Finland. | Health Technology |